Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder
Joshua BB Garfield, Hugh Piercy, Shalini Arunogiri, Dan I Lubman, Samuel C Campbell, Paul G Sanfilippo, Jeff Gavin, Malcolm Hopwood, Eli Kotler, Suzanne George, Goke Okedara, Lara R Piccoli, Victoria Manning
Trials | BMC | Published : 2021
BACKGROUND: Globally, methamphetamine use has increased in prevalence in recent years. In Australia, there has been a dramatic increase in numbers of people seeking treatment, including residential rehabilitation, for methamphetamine use disorder (MUD). While residential rehabilitation is more effective for MUD than withdrawal treatment (i.e. "detoxification") alone, relapse rates remain high, with approximately half of rehabilitation clients using methamphetamine within 3 months of rehabilitation. "Approach bias modification" (ABM) is a computerised cognitive training approach that aims to dampen automatically triggered impulses to approach drugs and drug-related stimuli. ABM has been demon..View full abstract
Awarded by National Centre for Clinical Research on Emerging Drugs (NCCRED)
This project is funded by the National Centre for Clinical Research on Emerging Drugs (NCCRED) (project number: NCR2SF10). NCCRED has played no role in the study design and will have no role in the collection, management, analysis, interpretation, or publication of data. The project sponsor is Monash University.